13-Cis retinoic acid can enhance the antitumor activity of non-replicating Sendai virus particle against neuroblastoma

Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool

(2010) Yasufumi Kaneda   Expert Opinion on Drug Delivery

Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells

(2010) Koji Hatano et al.   INTERNATIONAL JOURNAL OF CANCER

Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

(2009) Katherine K. Matthay et al.   JOURNAL OF CLINICAL ONCOLOGY

Characterization of Mouse Sialyltransferase Genes: Their Evolution and Diversity

(2008) Shou TAKASHIMA   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems

(2008) Yasufumi Kaneda   Expert Opinion on Drug Delivery

Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle

(2008) Yoshifumi Kawaguchi et al.   INTERNATIONAL JOURNAL OF CANCER